We are live on ! Find out more
PVI

Pura Vida Investments Portfolio holdings

AUM $14.9M
1-Year Est. Return 38.76%
This Fund
S&P 500
This Quarter Est. Return
+23.01%
1 Year Est. Return
+38.76%
3 Year Est. Return
+26.8%
5 Year Est. Return
+25.03%
10 Year Est. Return
+1,723.84%
AUM
$1.94B
AUM Growth
+$900M
Cap. Flow
+$775M
Cap. Flow %
39.93%
Top 10 Hldgs %
51.62%
Holding
194
New
73
Increased
41
Reduced
31
Closed
42

Top Buys

Rank Stock Value
1
COO icon
Cooper Companies
COO
+$24.5M
2
PPD
PPD, Inc. Common Stock
PPD
+$19M
3
OM icon
Outset Medical
OM
+$18.6M
4
AFIB
Acutus Medical Inc
AFIB
+$16.2M
5
VCEL icon
Vericel Corp
VCEL
+$14.9M

Top Sells

Rank Stock Value
1
LHCG
LHC Group LLC
LHCG
+$8.66M
2
INSP icon
Inspire Medical Systems
INSP
+$8.51M
3
LIVN icon
LivaNova
LIVN
+$7.29M
4
OSUR icon
OraSure Technologies
OSUR
+$6.64M
5
BSX icon
Boston Scientific
BSX
+$6.44M

Sector Composition

Rank Sector Weight
1 Healthcare 31.67%
2 Industrials 0.76%
3 Consumer Staples 0.45%
4 Energy 0.25%
5 Consumer Discretionary 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ABM icon
151
ABM Industries
ABM
$2.84B
– –
-131,200
Closed -$4.76M
ABT icon
152
PUT
Abbott
ABT
$192B
– –
-92,000
Closed -$8.41M
AMRN
153
Amarin Corp
AMRN
$297M
– –
-12,812
Closed -$1.77M
ATXS
154
DELISTED
Astria Therapeutics
ATXS
– –
-3,085
Closed -$119K
BSX icon
155
Boston Scientific
BSX
$74.5B
– –
-183,500
Closed -$6.44M
BTAI icon
156
BioXcel Therapeutics
BTAI
$32.7M
– –
-1,281
Closed -$1.09M
CERS icon
157
Cerus
CERS
$546M
– –
-566,321
Closed -$3.74M
COO icon
158
PUT
Cooper Companies
COO
$15B
– –
-70,000
Closed -$4.96M
CPRX
159
DELISTED
Catalyst Pharmaceutical
CPRX
– –
-789,603
Closed -$3.65M
CRBP icon
160
CALL
Corbus Pharmaceuticals
CRBP
$189M
– –
-5,797
Closed -$1.46M
INO icon
161
CALL
Inovio Pharmaceuticals
INO
$79.6M
– –
-3,333
Closed -$1.08M
LEGN icon
162
Legend Biotech
LEGN
$3.99B
– –
-20,500
Closed -$872K
LIVN icon
163
CALL
LivaNova
LIVN
$4.45B
– –
-102,000
Closed -$4.91M
LIVN icon
164
LivaNova
LIVN
$4.45B
– –
-151,473
Closed -$7.29M
MCRB icon
165
CALL
Seres Therapeutics
MCRB
$47.4M
– –
-12,800
Closed -$1.22M
MDT icon
166
PUT
Medtronic
MDT
$116B
– –
-63,500
Closed -$5.82M
MRK icon
167
Merck
MRK
$328B
– –
-72,437
Closed -$5.34M
MRSN
168
DELISTED
Mersana Therapeutics
MRSN
– –
-5,116
Closed -$2.99M
NVCR icon
169
CALL
NovoCure
NVCR
$2.05B
– –
-55,400
Closed -$3.29M
OSUR icon
170
OraSure Technologies
OSUR
$259M
– –
-485,600
Closed -$6.64M
QURE icon
171
uniQure
QURE
$3.13B
– –
-25,600
Closed -$1.15M
SRPT icon
172
PUT
Sarepta Therapeutics
SRPT
$1.94B
– –
-132,400
Closed -$21.2M
TGTX icon
173
TG Therapeutics
TGTX
$7.58B
– –
-141,364
Closed -$2.75M
TPST icon
174
CALL
Tempest Therapeutics
TPST
$19.3M
– –
-656
Closed -$225K
TRS icon
175
TriMas Corp
TRS
$1.41B
– –
-133,000
Closed -$3.19M
4 5 6
7
8

Similar funds

BCA
Boundary Creek Advisors New York $15.3M AUM 0.41% 1-Year Est. Return
RC
Raine Capital New York $14.1M AUM 33.16% 1-Year Est. Return
DOFI
DCVC Opportunity Fund II Palo Alto, California $13.9M AUM 8.04% 1-Year Est. Return
SCI
SkyBridge Capital II New York $13.1M AUM 3.36% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
GBCP
Glade Brook Capital Partners Greenwich, Connecticut $12.8M AUM
SCTC
Samsung C&T Corporation Seoul, South Korea $17.2M AUM 23.45% 1-Year Est. Return
M
MetLife New York $12.3M AUM 29% 1-Year Est. Return

Pura Vida Investments's Q3 2020 Portfolio in Review

As of Q3 2020, Pura Vida Investments held 194 positions worth $1.94B, up 87% from $1.04B the previous quarter. Its ten largest holdings account for 52% of the portfolio.

Pura Vida Investments deployed $775M of net new capital in Q3 2020, opening 73 new positions and adding to 41 existing holdings. Its largest new stake was Cooper Companies: 320,000 shares worth $27M.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, down from 38% a quarter earlier, followed by Industrials and Consumer Staples.

On the sell side, the largest reduction was LHC Group LLC, an estimated $8.66M trimmed.

  • Pura Vida Investments's largest Q3 2020 buy was Cooper Companies: 320,000 shares worth $27M.
  • Pura Vida Investments added most to Quotient Limited Ordinary Shares in Q3 2020, an estimated $11.6M increase.
  • Pura Vida Investments's biggest Q3 2020 reduction was LHC Group LLC, cutting an estimated $8.66M.
  • Pura Vida Investments fully exited LivaNova in Q3 2020, selling an estimated $7.29M.
  • Pura Vida Investments's ten largest holdings make up 52% of its $1.94B portfolio in Q3 2020.
  • Pura Vida Investments opened 73 new positions and closed 42 in Q3 2020.
  • Pura Vida Investments's portfolio value rose 87% quarter-over-quarter to $1.94B.

Based on Pura Vida Investments's 13F filing for Q3 2020, filed 16 Nov 2020.